C-BB3VPentara
clinical biostatistics, study design, integrity analytics
measurementoperating trials
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-BB3V
C-BB3VC-BB3Vclinical biostatistics, study design, integrity analytics
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Pentara clinical biostatistics, study design, integrity analytics
Pentara Brain Stride appears to be a neurodegeneration-focused clinical-trials analytics and services effort rather than a therapeutic program: Pentara presents it as biostatistics, data management, fraud/anomaly detection, regulatory support, and study-design support for clinical trials, with claimed relevance to Alzheimer’s and related disorders. The evidence supports a real operating team and publication activity, but it is still mostly self-authored company material with no project-specific outcome data in the excerpt, so the strongest claim is that this is research infrastructure for brain-health trials, not validated brain-health impact.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Pentara — Near-term readout · Lower middle. Derived deterministically from 26 extracted project(s). Most-advanced status: phase 3. Band: near_readout. Modifiers: +5 depth (3 programs at…
Source: Deterministic